Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of FGF9 for treatment and prevention of major depression

Administration of FGF9 for treatment and prevention of major depression

US Patent 9957568 · Granted May 1, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for decreasing depression-like behavior with connective tissue growth fac2019
Method for decreasing depression-like behavior with connective tissue growth fac2019
Method for decreasing depression-like behavior with connective tissue growth fac2019
Administration of FGF9 for treatment of anxiety2016
Administration of FGF9 for treatment of anxiety2016
Administration of FGF9 for treatment of anxiety2016
Methods for treating depression using NCAM peptide mimetics2016
Methods for treating depression using NCAM peptide mimetics2016
Methods for treating depression using NCAM peptide mimetics2016
Administration of FGF2 for treamtent of anxiety2013
Administration of FGF2 for treamtent of anxiety2013
Compositions and methods for diagnosing and treating neuropsychiatric disorders2010